AWS Health Innovation Podcast podcast

#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio

0:00
27:30
Reculer de 15 secondes
Avancer de 15 secondes
Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.

D'autres épisodes de "AWS Health Innovation Podcast"